Curanex Pharmaceuticals Inc (CURX)
8.60
+0.41 (4.95%)
Inactive · Last trade price on Sep 12, 2025
Curanex Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
238.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 26.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCURX News
- 5 weeks ago - Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters - GlobeNewsWire
- 7 weeks ago - U.S. IPO Weekly Recap: Quiet Week As IPO Market Gears Up For A Busy Fall - Seeking Alpha
- 7 weeks ago - Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering - GlobeNewsWire
- 2 months ago - Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering - GlobeNewsWire
- 1 year ago - Preclinical biopharma Curanex Pharmaceuticals files for a $10 million IPO - Renaissance Capital
- 1 year ago - Curanex Pharmaceuticals IPO Registration Document (S-1) - SEC